
Molecure Investor Relations Material
Latest events

Q4 2024
Molecure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Molecure S A
Access all reports
Molecure S.A. is a biotechnology company focused on the discovery and development of small molecule therapies for the treatment of inflammatory and fibrotic diseases, as well as cancer. The company leverages its proprietary research platforms to identify novel drug targets and advance its pipeline of investigational treatments. The company is headquartered in Warsaw, Poland, and its shares are listed on the WSE.
Key slides for Molecure S A


Investor Presentation
Molecure S A


Investor Presentation
Molecure S A
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MOC
Country
🇵🇱 Poland